PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / November 17, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical ...
We recently compiled a list of the 12 Best Low-Priced Pharma Stocks to Buy Right Now. Medicus Pharma Ltd. (NASDAQ:MDCX) is ...
View Medicus Pharma Ltd MDCX stock quote prices, financial information, real-time forecasts, and company news from CNN.
SkinJect®, a novel localized immuno-oncology precision product focused on non-melanoma skin diseases, especially basal cell carcinoma (BCC) and Gorlin Syndrome, a rare autosomal dominant disease also ...
In April, Medicus Pharma Ltd. (NASDAQ:MDCX) agreed to acquire all of Antev’s issued and outstanding shares on a share exchange. Antev is a clinical-stage biotech company developing Teverelix, a ...
TORONTO, June 4, 2025 /CNW/ - Medicus Pension Plan ™ published its annual report today, announcing its strong funded status of 152% as of January 1, 2025, along with a robust return of 9.1% in 2024.
Later on Wednesday, FFL Partners is expected to announce that it has acquired Medicus IT, a healthcare-focused managed service provider (MSP), from 424 Capital. PE Hub spoke with FFL partner Jonathon ...
Capital Brief on MSN
Echo IQ shares rally after securing $20m investment from Pro Medicus
More news: Shares in Echo IQ rocketed in afternoon trade after the medical technology company secured an investment deal of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results